# Allergic Versus Non Allergic Hypersensitivity Drug Reaction (BdDAllergo)

> **NCT03369509** · — · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 456 (actual)

## Conditions studied

- Allergic Hypersensitivity Drug Reaction Versus Non-allergic Hypersensitivity Drug Reaction Cross Reaction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03369509
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-29
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 456 (ACTUAL)
- **Why stopped:** departure of the investigator from the CHU Grenoble Alpes
- **Last updated:** 2019-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03369509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03369509, "Allergic Versus Non Allergic Hypersensitivity Drug Reaction (BdDAllergo)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03369509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*